Merit Medical Systems Share Holder Equity 2010-2023 | MMSI

Merit Medical Systems share holder equity from 2010 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
Merit Medical Systems Annual Share Holder Equity
(Millions of US $)
2023 $1,202
2022 $1,144
2021 $1,040
2020 $959
2019 $950
2018 $933
2017 $676
2016 $498
2015 $466
2014 $435
2013 $406
2012 $382
2011 $357
2010 $236
2009 $219
Merit Medical Systems Quarterly Share Holder Equity
(Millions of US $)
2023-12-31 $1,202
2023-09-30 $1,230
2023-06-30 $1,204
2023-03-31 $1,172
2022-12-31 $1,144
2022-09-30 $1,089
2022-06-30 $1,073
2022-03-31 $1,057
2021-12-31 $1,040
2021-09-30 $1,013
2021-06-30 $992
2021-03-31 $977
2020-12-31 $959
2020-09-30 $934
2020-06-30 $929
2020-03-31 $940
2019-12-31 $950
2019-09-30 $949
2019-06-30 $951
2019-03-31 $940
2018-12-31 $933
2018-09-30 $923
2018-06-30 $699
2018-03-31 $689
2017-12-31 $676
2017-09-30 $667
2017-06-30 $666
2017-03-31 $652
2016-12-31 $498
2016-09-30 $486
2016-06-30 $480
2016-03-31 $472
2015-12-31 $466
2015-09-30 $459
2015-06-30 $453
2015-03-31 $443
2014-12-31 $435
2014-09-30 $424
2014-06-30 $416
2014-03-31 $410
2013-12-31 $406
2013-09-30 $396
2013-06-30 $390
2013-03-31 $383
2012-12-31 $382
2012-09-30 $381
2012-06-30 $371
2012-03-31 $364
2011-12-31 $357
2011-09-30 $351
2011-06-30 $346
2011-03-31 $247
2010-12-31 $236
2010-09-30 $230
2010-06-30 $230
2010-03-31 $224
2009-12-31 $219
2009-09-30 $212
2009-06-30 $204
2009-03-31 $198
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.299B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $70.359B 18.83
Becton Dickinson (BDX) United States $67.554B 19.62
West Pharmaceutical Services (WST) United States $28.238B 47.74
Cardinal Health (CAH) United States $25.184B 15.14
Align Technology (ALGN) United States $23.613B 45.61
Cooper (COO) United States $17.928B 27.13
Labcorp (LH) United States $17.493B 14.94
Henry Schein (HSIC) United States $9.406B 16.27
DENTSPLY SIRONA (XRAY) United States $6.412B 16.90
Patterson (PDCO) United States $2.346B 11.24
STAAR Surgical (STAA) United States $2.337B 73.57
CONMED (CNMD) United States $2.156B 19.56
Atrion (ATRI) United States $0.747B 38.46
Lifevantage (LFVN) United States $0.079B 12.85
Pro-Dex (PDEX) United States $0.065B 24.67
Biolase (BIOL) United States $0.005B 0.00